213 related articles for article (PubMed ID: 24393743)
1. Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways.
Guillaumond F; Iovanna JL; Vasseur S
Arch Biochem Biophys; 2014 Mar; 545():69-73. PubMed ID: 24393743
[TBL] [Abstract][Full Text] [Related]
2. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.
Guillaumond F; Leca J; Olivares O; Lavaut MN; Vidal N; Berthezène P; Dusetti NJ; Loncle C; Calvo E; Turrini O; Iovanna JL; Tomasini R; Vasseur S
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3919-24. PubMed ID: 23407165
[TBL] [Abstract][Full Text] [Related]
3. Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze.
Olivares O; Vasseur S
Int J Cancer; 2016 Feb; 138(4):787-96. PubMed ID: 25732227
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer cell metabolism in pancreatic adenocarcinoma.
Cohen R; Neuzillet C; Tijeras-Raballand A; Faivre S; de Gramont A; Raymond E
Oncotarget; 2015 Jul; 6(19):16832-47. PubMed ID: 26164081
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.
Brandi J; Dando I; Pozza ED; Biondani G; Jenkins R; Elliott V; Park K; Fanelli G; Zolla L; Costello E; Scarpa A; Cecconi D; Palmieri M
J Proteomics; 2017 Jan; 150():310-322. PubMed ID: 27746256
[TBL] [Abstract][Full Text] [Related]
6. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
7. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors.
Daemen A; Peterson D; Sahu N; McCord R; Du X; Liu B; Kowanetz K; Hong R; Moffat J; Gao M; Boudreau A; Mroue R; Corson L; O'Brien T; Qing J; Sampath D; Merchant M; Yauch R; Manning G; Settleman J; Hatzivassiliou G; Evangelista M
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4410-7. PubMed ID: 26216984
[TBL] [Abstract][Full Text] [Related]
8. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
Halbrook CJ; Lyssiotis CA
Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
[TBL] [Abstract][Full Text] [Related]
9. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.
Sharma NS; Gupta VK; Garrido VT; Hadad R; Durden BC; Kesh K; Giri B; Ferrantella A; Dudeja V; Saluja A; Banerjee S
J Clin Invest; 2020 Jan; 130(1):451-465. PubMed ID: 31613799
[TBL] [Abstract][Full Text] [Related]
11. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells.
Srivastava S; Widmann S; Ho C; Nguyen D; Nguyen A; Premaratne A; Gustafsson JÅ; Lin CY
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348693
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling and pancreatic tumor development.
Lauth M; Toftgård R
Adv Cancer Res; 2011; 110():1-17. PubMed ID: 21704226
[TBL] [Abstract][Full Text] [Related]
13. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
[TBL] [Abstract][Full Text] [Related]
15. Advances in pancreatic cancer.
Kim EJ; Simeone DM
Curr Opin Gastroenterol; 2011 Sep; 27(5):460-6. PubMed ID: 21778878
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived proangiogenic cells in pancreatic cancer.
Mizukami Y
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration.
Costanza B; Rademaker G; Tiamiou A; De Tullio P; Leenders J; Blomme A; Bellier J; Bianchi E; Turtoi A; Delvenne P; Bellahcène A; Peulen O; Castronovo V
Int J Cancer; 2019 Sep; 145(6):1570-1584. PubMed ID: 30834519
[TBL] [Abstract][Full Text] [Related]
18. Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.
Xiang J; Liu L; Wang W; Xu H; Wu C; Xu J; Liu C; Long J; Ni Q; Yu X
Cancer Lett; 2015 Apr; 359(2):165-8. PubMed ID: 25617800
[TBL] [Abstract][Full Text] [Related]
19. Glutamine deprivation triggers NAGK-dependent hexosamine salvage.
Campbell S; Mesaros C; Izzo L; Affronti H; Noji M; Schaffer BE; Tsang T; Sun K; Trefely S; Kruijning S; Blenis J; Blair IA; Wellen KE
Elife; 2021 Nov; 10():. PubMed ID: 34844667
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody signature in human ductal pancreatic adenocarcinoma.
Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
